usaindiachamber
 
 
 HOME
 ABOUT US
 STRUCTURE
 AGENDA
 US-INDIA INVESTMENT COUNCIL
 CIO COUNCIL
 CIO ADVISORS
 BIOTECH, PHARMACEUTICALS AND MEDICAL DEVICES COUNCIL
 BPM ADVISORS
 POLICY & REPORTS
 EVENTS
 MEMBERSHIP
 MEMBERSHIP FORM
 INTERNSHIP/VOLUNTEERS
 LEGAL
 CONTACT US

  Untitled document

Current Events

Click here to register online 

Supported by

Government of India
Department of Biotechnology
Ministry of S & T


Department of Pharmaceuticals

Lead Sponsors
Aurigene

Biogen Idec

Jubilant Organosys

Merck

Schering Plough

Vertex

 

Knowledge Partner:

McKinsey & Company

Award Sponsor

Influence Technology - Partner of choice

Industry partner

NIPER
NIPER

Pharmexcil

Association of Biotechnology led enterprises

 

Award Sponsor

Influence Technology - Partner of choice

Industry partner

NIPER
NIPER

Pharmexcil

Association of Biotechnology led enterprises

 

 

US India BioPharma & Healthcare Summit 2009  

Hyatt Regency, Cambridge    
575 Memorial Drive, Cambridge, MA 02139, USA
Thursday, May 14, 2009      

Co-Chair
Dr. Martin Mackay, President Global R&D Pfizer
Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
Dr. Naresh Trehan, Chairman MediCity
Jeff Elton, Life Sciences Investor & Consultant

Advisory Board
Dr. Barry Bloom, Harvard University Distinguished Service Professor & Past Dean Harvard School of Public Health
George Bickerstaff, Managing Director, CRT Capital Group
William W.Chin,M.D., Vice President Discovery Research, Eli Lilly & Company
Venkat Jasti, Chairman & CEO, Suven Lifesciences
Dr. Ismail Kola, Sr. Vice President & CSO, Schering Plough
Reid Leonard, Executive Director, Merck & Co.
Dr. Peter Mueller, Executive Vice President & CSO, Vertex Pharmaceuticals
CSN Murthy, CEO, Aurigene Discovery
Dr. Michael Rosenblatt, Dean, Tufts University School of Medicine
Dr. K.V. Subramaniam, CEO, Reliance Life Sciences
Dr. Sridaran Natesan, PhD, Co-Leader - Stem Cell Initiative, Sanofi-avntis
Dr. Gunther Winkler, Sr. Vice President, Biogen Idec

Program Schedule (Program & Timings subject to change)

12-30 PM – 1-00 PM: Registration

1-00 PM – 1-10 PM: Welcome address remarks by Karun Rishi, President-USA-India Chamber of Commerce

1-10 PM – 1-35 PM: Release of Annual Position Paper by Dr. Martin Mackay

McKinsey & Company presentation of USA-India Chamber of Commerce commissioned annual Position Paper

1-35 PM – 2-30 PM: Panel Discussion:
Healthcare, Clinical Research and Industry-Academic Partnerships

P
anelists:  Dr. Gerald Keusch, Associate Provost, BU School of Public Health, Dr. David Lacey, Senior Vice President & Head of Research, Amgen, Dr. Michael Rosenlatt, Dean Tufts University School of Medicine, Joe Smith, MD, PhD, Vice President-Emerging Technologies, Johnson & Johnson, Sridhar Mosur, Chief Executive Officer, Jubilant Biosys

Moderator: Dr. William Chin, Vice President - Discovery Research & Clinical Investigation, Eli Lilly & Company

Introduction: Manni Kanti Pudi, President, GVK BioSciences

2-30 PM 2-55 PM: Keynote Address by Martin Mackay, President, Pfizer Global Research & Development

2-55 PM – 3-50 PM: Panel Discussion:
Funding Innovation, Cross Border Investment and M&A Trends

Panelists:  K.V.Subramaniam, President & CEO, Reliance Life Sciences; Jeff Collins, Executive in Residence, Pappas Ventures; Jeffrey Elton, Life Sciences Investor & Consultant; George Bickerstaff, Managing Director, CRT Investment Banking; Shrikumar Suryanarayan, Director General, ABLE

Moderator: Glen Giovanneti, Global Biotechnology Leader, Ernst & Young

Introduction: Banashri Bose Harrison, Minister (Commerce), Embassy of India

3-50 PM – 4-20 PMNetworking and Tea Break 

4-20 PM – 4-45 PM: Keynote Address by Nobel Laureate Dr. Sidney Altman

4-45 PM – 5-05 PM: Presentation by Department of Pharmaceuticals, Govt of India. Paresh Johri, Deputy Secretary

5-05 PM – 6-00 PM: Panel Discussion:
Drug discovery, Development and Collaborative Research

Panelists
:  Robert Armstrong, PhD, Vice President, Global External R&D, Eli Lilly; Venkat Jasti, Chairman & CEO, Suven Life Sciences; Ismail Kola, PhD, Senior Vice President- Discovery Research & Chief Scientific Officer, Schering-Plough; CSN Murthy, Chief Executive Officer, Aurigene Discovery; Dr. John Thompson, Vice President, Strategic Research Alliances, Vertex

Moderator: Ramesh Srinivasan, Principal, McKinsey and Company

IntroductionReid Leonard, PhD, Executive Director, External Research & Licensing, Merck & Co.

6-00 PM – 6-25 PM: Honoring Dr. Barry R. Bloom

Introduction by Dr. Gerald Keusch, Associate Provost, BU School of Public Health

Award Presentation by Dr. Martin Mackay and Karun Rishi

Address by Dr. Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Department of Immunology and Infectious Diseases, Harvard School of Public Health

6-25 PM – 6-35 PM: Closing Remarks - James Mullen President & CEO, Biogen Idec 

6-35 PM – 8-00 PM: Cocktails and Networking Reception - Charles View Ballroom, 16th Floor

Cocktails and Networking Reception

Highlights

  • Annual high profile summit of established and emerging Biotech, Pharmaceuticals, Medical Devices, Healthcare companies form the US and India, Venture Capitalists, Investment Bankers, Policy Makers and Academia
  • Release of USA India Chamber of Commerce commissioned McKinsey & Company Position Paper. See 2008 Summit details
  • THE Bio Pharma event in the world focused on US-India BioPharma, Medical Devices and Healthcare
  • Access to key people focused on US-India BioPharma & Healthcare and top tier investors
  • An ideal opportunity to enhance corporate visibility to people who matter
  • Large participation by CEOs, Chief Scientific Officers and Chief Medical Officers of large and emerging Bio, Pharma, Medical Devices and Healthcare companies
  • Participation by senior partners of top tier Life Sciences/Healthcare Venture Capitalist, Investment Bankers and Private Equity firms
  • A forum open only to senior executives
* Program and speakers subject to change

 

Registration fee: $750.
Limited seats available. Registration fee subject to change.
No walk-ins or at the door registration.             Register now
USA-India Chamber of Commerce reserves the right to decline a registration without assigning any reason.

 

Summit open only to Senior Biotech/Pharma/Medical-Devices/Healthcare Executives, Enterpreneurs, Venture Capitalists, Investment Bankers, Private Equity Firms, Policy makers and Academia.

Click here to register online

     Media Partners
      BioSpecturm       Nature Publishing Group       Express Healthcare       Indian Express       Express Pharma

USA India Chamber of Commerce

 

2007-08 Meetings & Roundtables by USA-India Chamber of Commerce

 

  1. Honorable Kamal Nath, Minister of Commerce and Industry
  2. Honorable Ashwani Kumar, Minister of State, Ministry of Commerce & Industry
  3. Gopal Pillai, Secretary, Department of Commerce, Ministry of Commerce & Industry
  4. Ajay Shankar, Secretary, Department of Industry, Ministry of Commerce & Industry
  5. Dr, Ajay Dua, Advisor, Department of Industry, Ministry of Commerce & Industry
  6. R. Gopalan, Additional Secretary; Jayant Dasgupta, Joint Secretary; PK Dash, Joint Secretary; Rajeev Kher, Joint Secretary; Amarendra Khatua, Joint Secretary, Ministry of Commerce & Industry
  7. Honorable Dr. Anbumani Ramadoss, Union Minister of Health & Family Welfare
  8. Naresh Dayal, Secretary, Ministry of Health & Family Welfare
  9. Dr. Surinder Singh, Drug Controller General of India
  10. Director General, Indian Council of Medical Research (ICMR)
  11. Ratan Tata, Chairman, Tata Sons and Co-Chairman of US-India CEO Forum
  12. Honorable Prithviraj Chauhan, Minister of State, Prime Minister’s Office
  13. C.B. Bhave, Chairman, Securities and Exchange Board of India
  14. Shivshankar Menon, Foreign Secretary, Ministry of External Affairs
  15. Honorable. Kapil Sibal, Minister of Science & Technology and Earth Sciences
  16. Dr. M.K. Bhan, Secretary, Department of Biotechnology
  17. N.S. Samant, Joint Secretary, Department of Biotechnology
  18. Ashok Kumar, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Petrochemicals
  19. Satwant Reddy, Advisor; Ministry of Chemicals & Petrochemicals
  20. Gurdyal Singh Sandhu, Joint Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Petrochemicals
  21. Arun Ramanathan , Secretary, Ministry of Finance
  22. Madhusudan Prasad, Joint Secretary; Kumar Sanjay Krishna, Joint Secretary, Ministry of Finance
  23. Honorable Subodh Kant Sahai, Minister of State, Ministry of Food Processing Industries
  24. Under Secretary, US Department of Commerce
  25. Assistant Secretary, US Department of Commerce
  26. Associate Administrator, Small Business Administration
  27. Honorable Montek Singh Ahluwalia, Deputy Chairman, Planning Commission
  28. Minister of Communication & IT
  29. Jainder Singh, Secretary, Department of IT, Ministry of Communications & IT
  30. Siddhartha Behura, Secretary, Department of Telecom, Ministry of Communications & IT
  31. Tejendra Khanna, Lt. Governor Delhi
  32. Chief Minister, Government of Karnataka
  33. Katta Naidu, Minister of IT/BT and Revenue, Government of Karnataka
  34. Secretary- Information Technology, Development Commissioner (Industries), Member Secretary Maharashtra Biotechnology Commission, Government of Maharashtra
  35. Industry, Industry organizations, State and Federal officials in the US
USA India Chamber of Commerce

Supported by
Government of India
Department of Biotechnology
Ministry of S & T

Lead sponsors
Alexandria Real Estate Equities

TVM Capital

Merck

Vertex

Biogen Idec

GILEAD. Advancing Theraputics. Improving Lives.

Fidelity International

Influence Technology - Partner of choice

 

Knowledge Partner: McKinsey & Company

Associate partner
Live MINT The Wall Street Journal

Industry partner
Pharmexcil
Association of Biotechnology led enterprises

 

Associate partner
Live MINT The Wall Street Journal

Industry partner
Pharmexcil
Association of Biotechnology led enterprises

 

 

US India BioPharma Summit 2008      

Hyatt Regency, Cambridge    
Friday, June 13, 2008      

1-30 PM – 2-00 PM: Registration
Master of Ceremonies: Hon. Andrew Maguire, PhD, Executive Director-GAVI
2-00 PM – 2-10 PM: Welcome address and opening remarks by Karun Rishi, President USA-India Chamber of Commerce
2-10 PM – 2-30 PM: McKinsey & Company presentation of USA-India Chamber of Commerce annual Position Paper
2-35 PM – 3-25 PM: Panel Discussion:
Drug Discovery, Collaborative Research and Strategic Alliances
Panelists:
    Dr. William Chin, Vice President - Discovery Research, Eli Lilly
    Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences
    Dr. Peter Mueller, Exe. Vice President & CSO, Vertex Pharmaceuticals
    Barbara Yanni, Chief Licensing Officer, Merck & Co.
    Dr. Rashmi Barbhaiya, Co-Founder and CEO, Advinus Therapeutics
3-30 PM – 3-55 PM: Official Release of Position Paper and Keynote address by Honorable Kapil Sibal, Minister of Science & Technology and Earth Sciences, Government of India *
3-55 PM – 4-25 PM: Networking and Tea Break
4-25 PM – 5-15 PM: Panel Discussion:
Funding Innovation, Investment Opportunities, Cross Border M&A trends
Panelists:
    Frederick Frank, Vice Chairman & Director, Lehman Brothers
    Dr. Helmut M. Schühsler, Managing Partner, TVM Capital
    Tom Andrews, Senior Vice President, Alexandria Real Estate Equities
    Sri Mosur, President & CEO, Jubilant Biosys Ltd.
    Dr. Jasmin Patel, Managing Director, Fidelity Capital Management (India)
5-15 PM – 5-40 PM: Keynote address by Dr. Surinder Singh, Drug Controller General of India *
5-40 PM – 6-00 PM: Introduction: James Mullen, President & CEO, Biogen Idec and past Chairman, Biotechnology Industry Organization (BIO)

Keynote address by Dr. Joshua Boger, President & CEO, Vertex Pharmaceuticals and Chairman, Biotechnology Industry Organization (BIO)

6-00 PM – 6-50 PM: Panel Discussion:
Drug Development & Manufacturing, Clinical Research and In/Out Licensing
Panelists:
    Dr. Mark Powell, Sr VP & Worldwide Head-Pharmaceutical Development, Bristol Myers & Squibb
    Gregg Alton, Senior Vice President, Gilead Sciences
    Dr. Gunther Winkler, Sr. Vice President, Biogen Idec
    Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.
    Dr. Dianne Kikta, Vice President Global Clinical, Wyeth
    Dr. Sreeni Devidas, Vice President, GVK BioSciences
6-50 PM – 7-00 PM: Closing Remarks
Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce
7-00 PM – 8-30 PM: Cocktails and Networking Reception
                             Charles View Ballroom, 16th Floor

 

  • 2007 Summit was sold out. Over 300 senior executives participated, Release of Position Paper on Indian Bio-Pharma industry. See 2007 Summit details
  • Great opportunity to meet US-India focused established and emerging Bio-Pharma companies and investors in one location
  • High power networking reception
  • An excellent opportunity to connect for Partnership, Selling, Sourcing, Financing and M&A

     Media Partners
      The scientist      Indian Express      BioSpecturm

USA India Chamber of Commerce

Sponsors

Department of Biotechnology, Ministry of Science & Technology, Government of India

Department of Biotechnology
Ministry of Science & Technology
Government of India

Alexandria Real Estate Equities

Vertex

Biogen Idec

Capital Group LLC

Genzyme

Holland + Knight

Merck
State Bank of India (SBI)
TCG Real Estate

Knowledge Partner:
Ernst and Young

Industry Partner:
Pharmexcil
Association of Biotechnology led enterprises

 

US India Biotech Summit - 2007            

Monday, May 7, 2007. 5:00 pm - 9:00 pm                  
Hotel Omni Parker House
                 
60 School Street, Boston, MA 02108, USA                 

2007 Summit details

5-00 pm – 5-15 pm: Registration
5-15 pm – 5-30 pm: Summit inauguration and remarks by James C. Mullen, Chairman Biotechnology Industry Organization (BIO), CEO & President, Biogen Idec
5-30 pm – 5-45 pm:
   Welcome address and opening remarks by
   Karun Rishi, President, USA-India Chamber of Commerce
Release of USA-India Chamber of Commerce-Ernst & Young Position Paper on Indian Biotech industry 5-45 pm - 6-30 pm: Panel Discussion (1):
Discovery, Development, IP & Regulatory Issues
Panelists:
   Dr. Alan Smith, Chief Scientific Officer, Genzyme
   Dr. Peter Mueller, Chief Scientific Officer, Vertex Pharmaceuticals
   Dr. Rashmi H.Barbhaiya, CEO and MD, Advinus Therapeutics
   Dr. Sridhar Mosur, Managing Director, Jubilant Chemsys Ltd
   Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.

Moderator:
   David C U'Prichard, PhD,
   Partner, Red Abbey Venture Partners and Care Capital

6-30 pm – 6-45 pm Keynote Address:
   Dr.M.K.Bhan, Secretary-Govt of India, Dept of Biotechnology
   Introduction to Dr. MK Bhan by Joel Marcus,
   CEO of Alexandria Real Estate Equities

6-45 pm - 7-30 pm: Panel Discussion (2):
   Investment Opportunities, Cross Border Investments, and
   M&A Trends in the Life Sciences industry (US-India)


Panelists:
   Dr. Helmut M. Schühsler, Managing Partner, TVM Capital
   Dr. David Gluckman, MD & Head of European Life Sciences, Lazard
   George Bickerstaff, Managing Director, CRT Capital Group
   Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
   Dr. Stephen Knight, Managing Partner, Fidelity Biosciences
Moderator:
   Utkarsh Palnitkar , Partner-Transaction Advisory Services,
   Industry Leader - Health Sciences, Ernst & Young

Closing remarks: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce

7-30 pm- 9 pm: Cocktails & Networking Reception

 

Media Partners
Indian Express            BioSpecturm            BIO International

USA India Chamber of Commerce

 

The Deal's BRIC Symposium

 

April 12, 2007           Agenda & Registration
Location: The Westin New York at Times Square
USA-India Camber of Commerce is the Association Partner of BRIC Symposium. USAIC members save 15% off the The Deal's BRICs Symposium.

M&A and Investment opportunities in key emerging economies continue to thrill and terrify US professionals. In this one-day symposium, an audience of bankers, strategic acquirers, private equity partners and other alternative investment will gather in New York to hear the strategies and perspective of the leading investors and dealmakers who are having significant success currently in Brazil, Russia, India and China (BRIC).

USA India Chamber of Commerce

 

India Healthcare Luncheon Business Roundtable

 

India Healthcare Luncheon Business Roundtable with Dr. Anbumani Ramadoss, Honorable Union Minister of Health, Government of India and Prof. N.K. Ganguly, Director General, Indian Council of Medical Research (ICMR).

Opening remarks: Prof. Barry R. Bloom, Dean, Harvard School of Public Health
Remarks: Karun Rishi, President, USA-India Chamber of Commerce
Q&A and open discussion

Date: Friday, March 30, 2007
Time: 12 pm - 2 pm

Location: Harvard Faculty Club, Cambridge, MA

  • Opportunities in the Indian Healthcare industry
  • Opportunities in India for US Healthcare, Biotech, Pharma and Medical Device companies
  • Public-Private partnership in Indian Healthcare

Business Roundtable open to C level and senior executives from Healthcare, Pharma, Biotech, Medical Devices, Investment firms and Academia.

Event is complementary for members.

 
USA India Chamber of Commerce

 

India Business Summit

 

Special focus on opportunities for US SME companies in India. The two day conference besides several keynotes will have sessions on IT, ITeS, Retail, Real Estate, Food Processing, Auto and Auto Components, Financing, Entrepreneurship, Policy, Market Access, Emerging sectors and Export opportunities.

Senior policy makers and key executives from Walmart, Citigroup, Bank of America, SBA, Coca-Cola, Kelloggs, Tishman Spyer, Parsons, IBM, Hero Group, UPS, Bharti, General Motors, EXIM Bank, and Proctor & Gamble etc will participate in the panel discussions.

Place: Maurya Sheraton Hotel, New Delhi, India

Date: Jan 23-25, 2007

USA India Chamber of Commerce

 

India Healthcare Business Roundtable

 

Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce

Remarks by Prof K. Srinath Reddy, Professor and Head, Department of Cardiology, All India Institute of Medical Sciences (AIIMS) and President, Public Health Foundation of India

Remarks by Prof. Barry R. Bloom, Dean, Harvard School of Public Health

Q&A and open discussion

Closing Remarks: Stephen Knight, Managing Partner, Fidelity Biosciences

Date: Wednesday, December 6, 2006
Time: 12:00 p.m.-2:00 p.m.

Location: Downtown Harvard Club Boston, Massachusetts

The discussion will focus on:

 

  • Opportunities for US Pharma, Biotech and Medical Device companies
  • Public-Private partnership in healthcare
  • Public Health Foundation of India
  • AIIMS research initiatives in electrophysiology, cardiomyopathies, gene therapy and stem cell therapy

 

Prof Reddy was recently appointed President of the Public Health Foundation of India. Dr. Reddy Chairs numerous healthcare commissions and committees in India and internationally.

Exciting things are happening in India’s healthcare sector. Industry, Academia, Research institutions and Investors in the US need to take a serious look at India opportunity.

This roundtable is only for senior executives.

Event is complementary for members.

 

USA India Chamber of Commerce

 

BUSINESS DEVELOPMENT MISSION TO INDIA
November 29 to December 5, 2006

 

USA-India Chamber of Commerce is pleased to support the Business Development Mission led by Amb. Franklin L. Lavin, Under Secretary for International Trade, U.S. Department of Commerce. This precedent-setting initiative, potentially involving the largest ever overseas delegation of its kind led by a U.S. Government official, will serve as the capstone of a year of successful activities conducted under the auspices of the U.S.-India Commercial Dialogue, honoring the commitment of President Bush and Indian Prime Minister Manmohan Singh to revitalize bilateral trade discussions.

This is a great opportunity to get access to India’s high-level business, industry, and government representatives and opportunities to gain timely insights into the country’s trade and investment climate.

We strongly recommend and encourage you participate and benefit from this important business mission to India.

For details please visit India Mission

USA India Chamber of Commerce

The New York Society of Security Analysts in association with USA-India Chamber of Commerce presents ‘Investing in Asia’ conference.

Date: Thursday, September 28, 2006
Time: 8:30 a.m.-5:00 p.m.

Location: NYSSA, 1177 Avenue of the Americas, 2nd floor
          (between 45th and 46th Streets), New York, NY 10036

          Photo ID required for access to the building.

Credit: PD/CE/CPE = 1

Asia has become a crucial part of the global economy, boasting three of the ten largest economies—China, Japan, and India—and contributing more than 35% of world GDP. Investment has been booming in recent years, with Asia accounting for about 40% of net private capital flows into emerging markets.

The region’s economy is now the fastest growing in the world, and contributes close to 50% of global growth. Aggregate GDP for Asia expanded by a robust 7.4% in 2005. This growth has been supported by a favorable external environment and continuing progress on domestic reform issues. Experts expect China and India to continue to be the fastest-growing countries in the region, with projected 2006 GDPs of 9.5% and 7.3%, respectively.

Where are the next best investment opportunities in Asia? Hear from the senior executives of growing public companies from the region, and learn what leading experts have to say about Asia’s economic outlook.

USA India Chamber of Commerce
Taj Hotels
Sponsor

USA-India Chamber of Commerce presents Business Lunch Roundtable with David Bohigian, Assistant Secretary, International Trade Administration, U.S. Department of Commerce.

Program

Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce
Introduction: Nigel Thompson, Executive Director, Merck
Business Roundtable with David Bohigian, Assistant Secretary, U.S. Department of Commerce
Closing Remarks: Michael Fondo, Director, Fidelity Investments

Date: Tuesday, May 2, 2006.
Time: 12 pm - 2 pm

Location: Fairmont Copley Plaza Hotel, Boston

Assistant Secretary Bohigian’s Market Access and Compliance (MAC) division identifies and overcomes trade barriers, resolves trade policy issues, and ensures that our trading partners fully meet their obligations under our trade agreements. MAC ensures access to world markets for American companies.

MAC focuses on issues such as: Intellectual Property and Piracy, Quotas, Standards, Customs, Transparency and Contract Sanctity, National Treatment and Good Governance.

This roundtable is only for senior executives.

Event is complementary for members.

USA India Chamber of Commerce
 

Annual International Business Forum and Networking Evening

Date: Tuesday, May 2, 2006.
Registration & Seminars: 2:30 pm - 6:00 pm
Networking reception: 6:30 pm - 8:00 pm
Location: One Financial Center, Boston, MA 02111

The Global Economic Outlook: Implications for International Business in the Year Ahead: Christopher Probyn, Chief International Economist, State Street Corporation

Keynote speaker: David Bohigian, Assistant Secretary, US Department of Commerce

Panel discussion: Assessing & Managing Risk in the Global Marketplace

The business forum will kick off with a Global Economic Outlook seminar, which will include information on global market indicators and implications for international business in the year ahead. The forum will also include a session on Assessing and Managing Risk in the Global Marketplace, featuring panelists who will discuss techniques for assessing and mitigating various risks of doing business internationally: global security; political, economic and credit risk; intellectual property protection and commercial risks; and regulatory compliance.

USA India Chamber of Commerce
Indian Express
Media Sponsor

Interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India

Date: Tuesday, March 14, 2006
Time: 11-45 am to 1-30 pm
Location: Downtown Boston

USA-India Chamber of Commerce presents an interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India, Washington DC. He is a senior diplomat and a key person responsible for trade and exim policy issues. He is also an expert on WTO issues. This will be the first briefing nationally discussing the trade agreements signed last week during President Bush's India visit.

Agenda:

  • Important trade agreements signed during President Bush's India visit & its impact on US-India trade.
  • Opportunities in India: Best prospect sectors for US companies
  • Indian Budget 2006 highlights- Budget was presented to the Indian parliament on Feb 28.
  • Q & A

 

This event is complementary for our members.

Event sponsor: McDermott Will & Emery LLP

USA India Chamber of Commerce
 

USA-India Chamber of Commerce and USIBC present an Executive Luncheon Business Roundtable with Satwant Reddy, Secretary to Government of India, Ministry of Chemicals. She is the top ranking official in the ministry. Her portfolio includes the regulation of all state-owned chemical companies, pharmaceuticals, and petrochemicals. Among other things, she is tasked responsibility for formulating India ’s data exclusivity and pharmaceutical price control policies

Date: January 27, 2006
Time: 11-30 AM to 2 PM
Location: Downtown Boston

It is a member’s only event for senior executives. This event is complementary for our members.

Please email to info@usaindiachamber.org if you are interested in attending.

USA India Chamber of Commerce
 
Jan 26, 2006, 6-30 pm

Dinner meeting with Ms. Satwant Reddy, Secretary to Government of India, Ministry of Chemicals & Petrochemicals and Prof. Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School and author of the book: 'Innovation and Its Discontents’: How Our Broken Patent System is Endangering Innovation and Progress. Exclusively for members and sponsors.

This roundtable is only for senior executives.

Event is complementary for members.

 
 

Home | About us | Agenda | Council | Policy | Events | Membership | Membership Form | Internship/Volunteers | Contact us